Abstract Details

Title Pharmacokinetic Rationale for mg-to-mg Overnight Switch from b.i.d. Immediate Release Topiramate (TPM-IR) to Extended-Release Once-Daily SPN-538 (Trokendi XR™)

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 244

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Reyna Duron, MD (UCLA/VA Medical Center)	No disclosure on file
Janet Johnson	No disclosure on file
Scott Brittain (Supernus Pharmaceuticals, Inc.)	No disclosure on file
Paolo Baroldi (Supernus Pharmaceuticals, Inc.)	No disclosure on file

�鶹��ýӳ��

�鶹��ýӳ��

Abstract Details